PRODIEM BULK FIBRE THERAPY POWDER SUGAR FREE 2 G / 10.2 G
METHYLCELLULOSE : 2 G / 10.2 G · DIN 02248226 · NOVARTIS CONSUMER HEALTH CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is PRODIEM BULK FIBRE THERAPY POWDER SUGAR FREE?
PRODIEM BULK FIBRE THERAPY POWDER SUGAR FREE 2 G / 10.2 G contains METHYLCELLULOSE : 2 G / 10.2 G. It is listed in the Health Canada Drug Product Database under DIN 02248226, held by NOVARTIS CONSUMER HEALTH CANADA INC., supplied as POWDER for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 18-Jul-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02248226 |
|---|---|
| Brand name | PRODIEM BULK FIBRE THERAPY POWDER SUGAR FREE |
| Generic / active ingredient | METHYLCELLULOSE : 2 G / 10.2 G |
| Manufacturer | NOVARTIS CONSUMER HEALTH CANADA INC. |
| Strength | 2 G / 10.2 G |
| Dosage form | POWDER |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AC06 METHYLCELLULOSE |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 18-Jul-2007 |
| Original market date | 2003-12-03 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AC06 METHYLCELLULOSE. 0 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ENTROCEL SOLUTION 1.8% | 1.8 % | SOLUTION | TYCO HEALTHCARE | CANCELLED POST MARKET | DIN 00750700 |
| METHYLAX | 2 G / 10.2 G | POWDER | SEAFORD PHARMACEUTICALS INC | APPROVED | DIN 02248253 |
| PRODIEM BULK FIBRE THERAPY POWDER | 2 G / 19 G | POWDER | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | DIN 02248225 |
| RESTORAFIBRE CAPLET | 500 MG | TABLET | BAYER INC | APPROVED | DIN 02461137 |
| RESTORAFIBRE POWDER SUGAR FREE | 2 G / 10.2 G | POWDER | BAYER INC | APPROVED | DIN 02461145 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.